OFFICE ADDRESS:
6247 Jarvis Ave
Newark, CA 94560

If your child is nearsighted (myopic), there’s exciting news that could change the way parents manage their children’s vision. The U.S. Food and Drug Administration (FDA) has officially approved Stellest™ lenses, the first spectacle lens specifically designed to slow the progression of myopia in children.
This marks a major advancement in children’s eye care, giving parents another proven option to help protect their child’s long-term vision.
Traditional eyeglasses correct blurry distance vision but don’t prevent a child’s myopia from worsening. That’s because they simply refocus light without addressing the eye growth that causes myopia to progress over time.
Stellest™ lenses work differently. Their unique optical technology helps manage how light focuses inside the eye, which clinical studies have shown can significantly slow myopia progression compared to regular lenses.
For families, this offers a new, non-invasive, easy-to-wear solution that can help reduce the risks linked to worsening myopia—such as retinal detachment, glaucoma, and other serious eye diseases later in life.
Childhood myopia is becoming increasingly common, driven by lifestyle factors like more screen time and less outdoor play. Without treatment, nearsightedness often worsens every year. The higher a child’s prescription, the greater their lifetime risk for eye disease.
That’s why early intervention is so important. Starting myopia treatment early can make a measurable difference in slowing progression and preserving healthy vision into adulthood.
As a Treehouse Eyes provider, we have significant experience treating myopia children. Our doctors use a comprehensive, personalized approach with evidence-based treatments such as:
If your child is nearsighted or has not yet started myopia treatment, now is the perfect time to learn about your options.
👉 Schedule your FREE virtual consultation today!
Together, we can help your child see better today—and give them better vision for life.